XRC and MAI contributed equally to this article.
Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface
Version of Record online: 2 OCT 2012
© 2012 The Authors. Immunology © 2012 Blackwell Publishing Ltd
Volume 137, Issue 3, pages 214–225, November 2012
How to Cite
Rovira-Clavé, X., Angulo-Ibáñez, M., Noguer, O., Espel, E. and Reina, M. (2012), Syndecan-2 can promote clearance of T-cell receptor/CD3 from the cell surface. Immunology, 137: 214–225. doi: 10.1111/j.1365-2567.2012.03626.x
- Issue online: 2 OCT 2012
- Version of Record online: 2 OCT 2012
- Accepted manuscript online: 10 AUG 2012 10:57AM EST
- Manuscript Accepted: 13 JUL 2012
- Manuscript Revised: 10 JUL 2012
- Manuscript Received: 1 APR 2012
- Spanish Ministry of Education and Science. Grant Number: SAF2004-05481
Figure S1. Expression of SDC2 in resting and activated primary CD4+ T cells.
Figure S2. Expression of Fas, CD69, MHC class I, CD4 and transferrin receptor (TfR) in sdc2-transfected and control untransfected Jurkat cells as analysed by flow cytometry.
Figure S3. CD3-stimulation of CD4 T cells triggers T-cell receptor ζ degradation.
Figure S4. Intracellular location of internalized CD3ε in CD4 T lymphocytes.
Figure S5. SDC2-mediated T-cell receptor/CD3 down-regulation is independent of Arf6 activity.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.